Company intelligence / Profile preview

Heart & Lung Health

London, United Kingdom

Ownership: Private
Employees: ~70
Development stage: Other

Overview

HLH is the leading UK specialist teleradiology network focusing on lung cancer screening and cardiac imaging analysis, leveraging AI tools such as CaRi-Heart to enable early diagnosis and subspecialty expert reporting for the NHS Targeted Lung Health Check. HLH reports at commercial scale and is the premier source of reporting in the NHS England lung cancer screening pathway. Clinical results indicate improved early detection capability and national impact.

Therapeutic areas: OncologyPulmonologyCardiovascular
Modalities: DeviceArtificial intelligence-enabled softwareDiagnostic imaging
Industry: Medical Imaging

Partnerships

Caristo DiagnosticsAidence

Beyond the preview

Go deeper on Heart & Lung Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heart & Lung Health.

Explore the full profile